ELDICO Scientific announces sale to Holodiag

Today, 26th November 2024, ELDICO Scientifc AG is proudly announcing the sale of one more dedicated electron diffractometer, the ELDICO ED-1 to yet another CRO (contract research organisation). Holodiag, a leader in providing solid and crystallization services to pharmaceutical industry with a strong focus on material analysis, has chosen ELDICO. This sale will mark a significant step forward in empowering innovative structural characterization solutions for the pharmaceutical sector as Holodiag will be able to provide electron diffraction as an additional technique for solid state analysis and screening, demonstrating Holodiag’s commitment to innovation and delivering the best solutions in material characterization.

Holodiag’s adoption of Eldico’s electron diffractometer highlights the increasing demand for precise and efficient tools in analyzing challenging materials for the Pharmaceutical Industry. The ELDICO ED-1 will be deployed not only for solving crystal structures of nanocrystals but also in finding phase impurities and crystalline traces in amorphous substances and elucidating molecular structures, all critical steps for drug development and quality assurance. Eldico’s electron diffraction technology offers unmatched accuracy, efficiency, and reliability, enabling companies like Holodiag to elevate their research analysis capabilities.

“This partnership with Holodiag underscores the transformative potential of electron diffraction in the pharmaceutical industry,” said Dr. James Berwick CEO at Eldico Scientific. “We are excited to see our technology driving innovation in material analysis and contributing to the development of safer, more effective pharmaceutical products. It is also impressive how contract research organisations are driving this change adding electron diffraction to their portfolio of analytical devices”

“We are thrilled to integrate Eldico Scientific’s state-of-the-art electron diffractometer into our operations,” said Pierric Marchand Founder and General Manager of Holodiag. “This instrument is a game-changer for our work in analyzing nanocrystalline and complex pharmaceutical materials. It not only improves our efficiency but also ensures unparalleled accuracy in our research and quality assurance processes. We look forward to leveraging this technology to better serve our clients and accelerate advancements in the pharmaceutical industry.”

About Eldico Scientific:
Eldico Scientific is a leading provider of advanced electron diffraction solutions, dedicated to empowering researchers to gain precise insights into the atomic and molecular structure of crystalline compounds. With state-of-the-art electron diffraction instruments and customer centred services, Eldico Scientific empowers scientists and industries to push the frontiers of pharmaceutical, chemical and materials research.

Website: www.eldico-scientific.com 

About Holodiag:
Holodiag is a leader in providing solid and crystallization services to pharmaceutical industry with a strong focus on material analysis and life sciences industries. The company provides high-precision material characterization solutions to accelerate innovation and ensure the highest quality standards in drug development. Since July 2024, the Italian CDMO Icrom has acquired Holodiag, now both being part of Proxis Development, a French industrial group.

Website: www.holodiag.com

For media inquiries, please contact:
Eldico:
Alessia Portieri, Sales Manager
portieri@eldico.ch 

Holodiag
Pierric Marchand, CEO

pierric.marchand@holodiag.com

ELDICO ED-1